Evidence map›Paper›PMID 24400953›Full record

Trial reportBritish journal of clinical pharmacology2014

Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia.

Simone M C Spoorenberg, Vera H M Deneer, Jan C Grutters, Astrid E Pulles, G P Paul Voorn, Ger T Rijkers, Willem Jan W Bos, Ewoudt M W van de Garde

4 registry-linked trialsOpen access · bronzeAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in British journal of clinical pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01390012 phase3completednot on this map

Oral Versus Intravenous Dexamethasone in Community-Acquired Pneumonia

TypeinterventionalSponsorSt. Antonius HospitalRan2011 to 2012Enrolled30ConditionsPneumoniaArmsDexamethasone tablet 6 mg, Dexamethasone injection 4 mg
NCT04528329 phase4unknown statusnot on this mapstarted 2021, after this paper: background citation

Anosmia and / or Ageusia in COVID-19: Timeline, Treatment With Early Corticosteroid and Recovery

TypeinterventionalSponsorClinAmygateRan2021 to 2023Enrolled300ConditionsCovid19, AnosmiaArmsEarly-Dexamethasone, Late dexamethazone
NCT04530409 phase4unknown statusnot on this mapstarted 2021, after this paper: background citation

Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-up

TypeinterventionalSponsorClinAmygateRan2021 to 2023Enrolled752ConditionsCovid19, CorticosteroidsArmsEarly-Corticosteroids
NCT06428630 early_phase1withdrawnnot on this mapstarted 2025, after this paper: background citation

Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus

TypeinterventionalSponsorTufts UniversityRan2025 to 2027Enrolled0ConditionsOral Lichen Planus, Oral Lichenoid ReactionArmsdexamethasone oral rinse
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 91 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.Frontiers in cellular and infection microbiology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. A cell culture system to model pharmacokinetics using adjustable-volume perfused mixing chambers.Toxicology in vitro : an international journal published in association with BIBRA · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Simone M C SpoorenbergDepartment of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.
Vera H M Deneer
Jan C Grutters
Astrid E Pulles
G P Paul Voorn
Ger T Rijkers
Willem Jan W Bos
Ewoudt M W van de Garde
St. Antonius Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe use of corticosteroids as adjunctive therapy might be effective in patients with community-acquired pneumonia (CAP). Oral administration of dexamethasone is a practical and safer alternative to the intravenous route. Since patients hospitalized with pneumonia might have delayed gastric emptying, this study explored systemic exposure in terms of area under the concentration-time curve (AUC) of oral dexamethasone in patients hospitalized with CAP.

methodsIn this randomized, open label study, 30 patients admitted with CAP were randomized to receive either 4 mg intravenous or 6 mg oral dexamethasone for 4 consecutive days. Serial blood samples were obtained before and after drug administration.

resultsMedian AUC to infinity was 626 μg l(-1)  h (IQR 401-1161) for the intravenous group and 774 μg l(-1)  h (IQR 618-1146) for the oral group. The AUC ratio of 6 mg oral and 4 mg intravenous dexamethasone was 1.22 (95% confidence interval (CI) 0.81, 1.82), which represents a bioavailability of 81% (95% CI 54, 121) after correction for differences in dexamethasone dose.

conclusionsBioavailability of oral dexamethasone in patients hospitalized with pneumonia is sufficient. This makes oral dexamethasone an appropriate alternative for intravenous administration in these patients.

Indexed as

Administration, OralAgedBiological AvailabilityCommunity-Acquired InfectionsDexamethasoneFemaleGlucocorticoidsHospitalizationHumansInjections, IntravenousMalePneumoniaDexamethasoneGlucocorticoidsbioavailabilityCAPcommunity-acquired pneumoniadexamethasoneintravenousoral

Identifiers

PMID24400953
PMCPMC4168382
OpenAlexW1591670127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.